Transcript
Page 1: Drug Discovery: New Models for Investigating Thrombosis in Drug Compounds
Page 2: Drug Discovery: New Models for Investigating Thrombosis in Drug Compounds

CorDynamics conducts thrombosis experiments – using small and large animals

Mouse ferric chloride model of arterial thrombosis

1) instrumentation to monitor carotid artery flow

- monitor artery flow prior to and after FeCl3

- FeCl3 migrates to lumen, results in endothelial injury

2) administer putative anti-thrombotic prior to FeCl3

-monitor for development of thrombus

-use real-time monitor of blood flow, time to occlusion

Pharmacological validation

- heparin (anticoagulant)

MOUSE THROMBOSIS MODEL

Page 3: Drug Discovery: New Models for Investigating Thrombosis in Drug Compounds

Effects of heparin on carotid artery blood flow

MOUSE THROMBOSIS MODEL

0.0

0.5

1.0

1.5

2.0

2.5

3.0

3.5

-5 5 15 25 35 45 55 65

Car

oti

d B

loo

d F

low

(m

L/m

in)

Time (minutes)

Effects of Heparin on Ferric Chloride (3.5 %)-Induced Carotid Arterial Thrombosis in the Mouse

[vertical line is FeCl3 exposure]

Vehicle (0.9% NaCl, n=5)

Heparin (200U/kg, n=5)

Page 4: Drug Discovery: New Models for Investigating Thrombosis in Drug Compounds

Effects of heparin on time to occlusion

MOUSE THROMBOSIS MODEL

0

10

20

30

40

50

60

70

Vehicle (0.9% NaCl, n=5) Heparin (200U/kg) (n=5)

Tim

e (m

inut

es)

Effects of Heparin on the Ferric Chloride (3.5%)-Induced Carotid Arterial Thrombosis in the Mouse

Occlusion Time

No occlusion

Page 5: Drug Discovery: New Models for Investigating Thrombosis in Drug Compounds

For more information, on this model and our other drug discovery and drug safety

capabilities, please visit us at www.cordynamics.com


Recommended